| 14th Jun 2023 3:31 pm |
RNS |
PDS Announces Achievement of Efficacy Threshold |
| 7th Jun 2023 7:00 am |
RNS |
Director/PDMR Shareholding |
| 6th Jun 2023 7:00 am |
RNS |
Notice of AGM |
| 31st May 2023 7:01 am |
RNS |
Preliminary Results for the year ended 31 Dec 2022 |
| 31st May 2023 7:00 am |
RNS |
Board Changes |
| 26th May 2023 9:39 am |
RNS |
PDS Biotech Announces Interim Data |
| 24th May 2023 7:00 am |
RNS |
Sofant and Inmarsat announce joint development |
| 15th May 2023 3:16 pm |
RNS |
PDS Business Update and First Quarter Results |
| 2nd May 2023 7:00 am |
RNS |
Glycotest, Inc. Fundraising |
| 3rd Apr 2023 7:00 am |
RNS |
Business Update |
| 30th Mar 2023 3:51 pm |
RNS |
PDS Update |
| 28th Mar 2023 3:50 pm |
RNS |
PDS Business Update and 2022 Financial Results |
| 28th Feb 2023 7:00 am |
RNS |
Related party loan to ProAxsis Limited |
| 27th Feb 2023 3:28 pm |
RNS |
PDS completes FDA meeting for triple combination |
| 10th Feb 2023 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 10th Feb 2023 2:00 pm |
RNS |
Price Monitoring Extension |
| 10th Feb 2023 11:05 am |
RNS |
Second Price Monitoring Extn |
| 10th Feb 2023 11:00 am |
RNS |
Price Monitoring Extension |
| 1st Feb 2023 7:00 am |
RNS |
Board Change |
| 3rd Jan 2023 1:31 pm |
RNS |
PDS Announces Exclusive Global License Agreement |
| 28th Dec 2022 3:05 pm |
RNS |
PDS Biotech: Median Overall Survival announcement |
| 16th Dec 2022 7:00 am |
RNS |
PDS: HPV16 Head and Neck Cancer announcement |
| 12th Dec 2022 2:00 pm |
RNS |
Board Changes; Options; Co-Investment Agreement |
| 29th Nov 2022 7:00 am |
RNS |
EMV C leads £4.2m round in 5G and SATCOM leader |
| 14th Nov 2022 2:50 pm |
RNS |
PDS Q3 Results and Business Update |
| 14th Nov 2022 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 14th Nov 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 9th Nov 2022 7:00 am |
RNS |
Board Change |
| 7th Nov 2022 3:40 pm |
RNS |
PDS reports presentation of data at cancer society |
| 20th Oct 2022 7:00 am |
RNS |
EMV Capital secures investment in Ventive |
| 11th Oct 2022 4:00 pm |
RNS |
PDS Update |
| 3rd Oct 2022 1:56 pm |
RNS |
PDS completes End-of-Phase 2 meeting with FDA |
| 30th Sep 2022 7:00 am |
RNS |
Half-year Report |
| 25th Aug 2022 7:00 am |
RNS |
PDS Completes $35 Million Financing Agreement |
| 16th Aug 2022 7:00 am |
RNS |
Acquisition of 30% Vortex stake & new Vortex CEO |
| 8th Aug 2022 4:45 pm |
RNS |
PDS Reports Q2 2022 Results & Business Update |
| 29th Jun 2022 2:05 pm |
RNS |
Result of AGM |
| 28th Jun 2022 9:15 am |
RNS |
Holding(s) in Company |
| 27th Jun 2022 8:30 am |
RNS |
Director/PDMR Shareholding |
| 27th Jun 2022 8:30 am |
RNS |
Holding(s) in Company |
